Urogen Pharma (URGN)
NASDAQ:URGN
US Market
Advertisement

Urogen Pharma (URGN) Technical Analysis

Compare
643 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Urogen Pharma’s (URGN) Moving Averages Convergence Divergence (MACD) indicator is 1.53, suggesting Urogen Pharma is a Sell.
Urogen Pharma’s (URGN) 20-Day exponential moving average is 20.88, while Urogen Pharma’s (URGN) share price is $25.14, making it a Buy.
Urogen Pharma’s (URGN) 50-Day exponential moving average is 19.31, while Urogen Pharma’s (URGN) share price is $25.14, making it a Buy.

Urogen Pharma (URGN) Pivot Points

Nov 13, 2025, 02:38 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
21.57
22.21
22.92
23.57
24.28
24.92
25.63
Fibonacci
22.21
22.73
23.05
23.57
24.09
24.41
24.92
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Urogen Pharma (URGN) Moving Averages

Nov 13, 2025, 02:38 PM
Period
Simple
Exponential
MA5
23.74Buy
23.51Buy
MA10
21.87Buy
22.29Buy
MA20
20.18Buy
20.88Buy
MA50
18.95Buy
19.31Buy
MA100
18.08Buy
17.64Buy
MA200
13.98Buy
14.80Buy
Urogen Pharma’s (URGN) 10-Day exponential moving average is 22.29, while Urogen Pharma’s (URGN) share price is $25.14, making it a Buy.
Urogen Pharma’s (URGN) 100-Day exponential moving average is 17.64, while Urogen Pharma’s (URGN) share price is $25.14, making it a Buy.
Urogen Pharma’s (URGN) stock price is $25.14 and Urogen Pharma’s (URGN) 50-day simple moving average is 18.95, creating a Buy signal.
Urogen Pharma’s (URGN) stock price is $25.14 and Urogen Pharma’s (URGN) 100-day simple moving average is 18.08, creating a Buy signal.
Urogen Pharma’s (URGN) stock price is $25.14 and Urogen Pharma’s (URGN) 200-day simple moving average is 13.98, creating a Buy signal.

Urogen Pharma (URGN) Technical Indicators

Nov 13, 2025, 02:38 PM
Name
Value
Implied Action
RSI (14)
73.32
Sell
STOCH (9,6)
84.83
Sell
STOCHRSI (14)
87.11
Sell
MACD (12,26)
1.53
Sell
ADX (14)
28.81
Neutral
Williams %R
-0.64
Sell
CCI (14)
170.73
Sell
ATR (14)
1.56
-
Ultimate Oscillator
69.69
Neutral
ROC
45.07
Buy
Urogen Pharma’s (URGN) Relative Strength Index (RSI) is 73.32, creating a Sell signal.
Urogen Pharma’s (URGN) Trend Strength Indicator (ADX) is 28.81, creating a Neutral signal.
Urogen Pharma’s (URGN) Commodity Channel Index (CCI) is 170.73, creating a Sell signal.
Urogen Pharma’s (URGN) Price Rate of Change (ROC) is 45.07, creating a Buy signal.

FAQ

Is URGN a Buy, Hold, or Sell?
Based on URGN’s technical indicators, URGN is a Buy.
    What is URGN’s RSI (14)?
    URGN’s RSI (14) is 73.32, which suggests URGN is a Sell.
      What is URGN’s MACD?
      URGN’s MACD is 1.53, which suggests URGN is a Sell.
        What is URGN’s 5-day moving average?
        URGN’s 5-day moving average is 23.74, which suggests URGN is a Buy.
          What is URGN’s 20-day moving average?
          URGN 20-day moving average is 20.18, which suggests URGN is a Buy.
            What is URGN’s 50-day moving average?
            URGN’s 50-day moving average is 18.95, which suggests URGN is a Buy.
              What is URGN’s 200-day moving average?
              URGN’s 200-day moving average is 13.98, which suggests URGN is a Buy.
                What is URGN’s Williams % R (14)?
                URGN’s Williams % R (14) is -0.64, which suggests URGN is a Sell.
                  What is URGN’s CCI (14)?
                  URGN’s CCI (14) is 170.73, which suggests URGN is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis